Insider Trading & Ownership - Valle Franco

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Valle Franco
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-11
Purchase
2024-06-12
4:30 pm
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
12,509$4.4257$55,36142,500
(Direct)
View
2022-11-11
Purchase
2022-11-14
4:30 pm
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
4,100$7.6307$31,28617,407
(Direct)
View
2022-01-14
Purchase
2022-01-18
7:00 pm
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
10,000$8.6767$86,76710,000
(Direct)
View
2021-01-11
Sale
2021-01-13
4:05 pm
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
3,247$125.52$407,56050,447
(Direct)
View
2020-11-09
Sale
2020-11-10
4:05 pm
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
1,623$74.93$121,60927,597
(Direct)
View
2020-10-07
Sale
2020-10-09
5:23 pm
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
10,643$74.97$797,89963,639
(Direct)
View
2020-04-20
Sale
2020-04-22
4:05 pm
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
2,000$49.79$99,58039,419
(Direct)
View
2020-03-26
Sale
2020-03-30
4:23 pm
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
5,000$48.26$241,31041,419
(Direct)
View
2020-03-02
Sale
2020-03-04
4:08 pm
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
3,000$52.33$156,98046,419
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-30
Option Award
2024-12-02
4:30 pm
N/A
N/A
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
495$6.15442,995
(Direct)
View
2024-05-31
Option Award
2024-06-12
4:30 pm
N/A
N/A
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
4,448$3.782542,500
(Direct)
View
2024-01-17
Option Award
2024-01-18
4:30 pm
N/A
2034-01-16
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
145,245$0145,245
(Direct)
View
2023-11-30
Option Award
2023-12-01
5:58 pm
N/A
N/A
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
1,345$3.782525,543
(Direct)
View
2023-05-31
Option Award
2023-06-02
5:01 pm
N/A
N/A
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
4,273$3.782524,198
(Direct)
View
2023-01-06
Option Award
2023-01-10
5:00 pm
N/A
2033-01-05
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
126,300$0126,300
(Direct)
View
2022-11-30
Option Award
2022-12-02
4:30 pm
N/A
N/A
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
2,518$3.782519,925
(Direct)
View
2022-05-31
Option Award
2022-06-01
6:00 pm
N/A
N/A
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
3,307$4.666513,307
(Direct)
View
2021-12-04
Option Award
2021-12-07
5:25 pm
N/A
2031-12-03
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
144,770$0144,770
(Direct)
View
2021-08-03
Option Award
2021-08-05
7:25 pm
N/A
2031-07-25
Biomea Fusion Inc.BMEAValle Franco
Chief Financial Officer
165,000$0165,000
(Direct)
View
2021-01-26
Disposition
2021-01-28
7:22 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
24,350$00
(Direct)
View
2021-01-11
Exercise
2021-01-13
4:05 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
3,247$050,447
(Direct)
View
2021-01-11
Exercise
2021-01-13
4:05 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
3,247$7.2450,447
(Direct)
View
2020-11-09
Exercise
2020-11-10
4:05 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
1,623$027,597
(Direct)
View
2020-11-09
Exercise
2020-11-10
4:05 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
1,623$7.2427,597
(Direct)
View
2020-10-07
Exercise
2020-10-09
5:23 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
10,199$063,639
(Direct)
View
2020-10-07
Exercise
2020-10-09
5:23 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
10,199$7.2463,639
(Direct)
View
2020-05-31
Option Award
2020-06-05
4:05 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
444$41.57444
(Direct)
View
2020-04-20
Exercise
2020-04-22
4:05 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
2,000$039,419
(Direct)
View
2020-04-20
Exercise
2020-04-22
4:05 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
2,000$7.2439,419
(Direct)
View
2020-03-26
Exercise
2020-03-30
4:23 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
5,000$041,419
(Direct)
View
2020-03-26
Exercise
2020-03-30
4:23 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
5,000$7.2441,419
(Direct)
View
2020-03-02
Exercise
2020-03-04
4:08 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
3,000$046,419
(Direct)
View
2020-03-02
Exercise
2020-03-04
4:08 pm
N/A
N/A
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
3,000$7.2446,419
(Direct)
View

Ownership
2020-01-09
6:51 pm
N/A
2028-05-06
Eidos Therapeutics Inc.EIDXValle Franco
Senior Vice President, Finance
0$049,419
(Direct)
View